Nicholas Banovich, Ph.D.
Associate Professor and Co-director
Bioinnovation and Genome Science  
Sara Byron, Ph.D.
Research Associate Professor and Co-director
Bioinnovation and Genome Sciences Division 
Floris Barthel, M.D.
Assistant Professor
Bioinnovation and Genome Sciences Division 
Heini M. Natri, Ph.D.
Research Assistant Professor
Bioinnovation and Genome Sciences Division 
Jeffrey Trent, Ph.D., F.A.C.M.G.G.
TGen President & Research Director
 
TGen’s Nicholas Banovich, Ph.D., secures over $8.2 million in NIH grants for pulmonary disease research

Nicholas Banovich, Ph.D., associate professor and division director of Bioinnovation and Genome Sciences at TGen, part of City of Hope, will lead or co-lead three collaborative grants totaling over $22 million, with $8.2 million supporting research at TGen.

Read Article

TGen and partners in Longevity Consortium receive $45 million grant

PHOENIX, Ariz. — Oct. 29, 2024 — TGen, part of City of Hope, and its partners in the Longevity Consortium have received a five-year, $45 million grant to move the consortium’s work to its next stage: integrating results from numerous studies about the factors that contribute to longer and healthier lives.

Read Article

TGen’s Runway for Research Raises Over $214,000 for Women’s Cancer Research

PHOENIX, AZ (October 28, 2024) – The TGen Foundation today announced that its 4th Annual Runway for Research raised over $214,000 to support laboratory and clinical research of women’s cancers at TGen, part of City of Hope.

Read Article

Soteria Precision Medicine Foundation Partners with Translational Genomics Research Institute (TGen) to Inform Cancer Care for Special Operations Forces

PHOENIX, AZ (Oct. 23, 2024) — Soteria Precision Medicine Foundation, a non-profit organization dedicated to providing leading-edge patient precision medicine navigation services to individuals with cancer diagnoses, today announced a partnership with the Translational Genomics Research Institute (TGen), part of City of Hope, to provide precision medicine navigation for Special Operation Forces in their battle against cancer.

Read Article

TGen gains early access to Illumina Protein Prep

PHOENIX, AZ (October 3, 2024) – The Translational Genomics Research Institute (TGen), part of City of Hope, is collaborating with Illumina, Inc., to become one of the first Early Access sites for its NGS-based proteomics solution, featuring the SOMAmer® Reagents from Standard Biotools.

Read Article







City of Hope and TGen
Together, City of Hope Phoenix and TGen are accelerating the development of precision medicine enabled by advanced genomics, and working to bring those advances to more patients faster than ever before. This work will not only deliver tremendous benefits to Arizona and its people, but also patients all across the United States through City of Hope's national footprint of cancer centers.


 
Get our stories delivered